APA (7th ed.) Citation

Beketova, T. V., Levina, N. O., Uskova, Y. A., Rozanova, I. V., Dubinskaia, M. V., Evdokimova, S. A., . . . Devyatkin, A. V. (2024). Pre-exposure prophylaxis of COVID-19 with tixagevimab/cilgavimab (Evusheld) in 63 rituximab-treated patients with ANCA-associated systemic vasculitis: Two-year follow-up results. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Beketova, T. V., N. O. Levina, Yu. A. Uskova, I. V. Rozanova, M. V. Dubinskaia, S. A. Evdokimova, V. V. Babak, M. F. Beketova, and A. V. Devyatkin. Pre-exposure Prophylaxis of COVID-19 with Tixagevimab/cilgavimab (Evusheld) in 63 Rituximab-treated Patients with ANCA-associated Systemic Vasculitis: Two-year Follow-up Results. IMA PRESS LLC, 2024.

MLA (9th ed.) Citation

Beketova, T. V., et al. Pre-exposure Prophylaxis of COVID-19 with Tixagevimab/cilgavimab (Evusheld) in 63 Rituximab-treated Patients with ANCA-associated Systemic Vasculitis: Two-year Follow-up Results. IMA PRESS LLC, 2024.